母亲先前存在的糖尿病:对先天性心脏病的非遗传风险因素
Stéphanie Ibrahim1, Bénédicte Gaborit2, Marien Lenoir3
1Aix Marseille University, INSERM, INRAE, C2VN, 13005 Marseille, France.
International journal of molecular sciences
|November 25, 2023
概括
怀孕期间产妇糖尿病增加了先天性心脏缺陷的风险. 高血糖可能通过遗传,表观遗传和氧化应激途径引起心脏异常,需要进一步研究预防.
科学领域:
- 心脏病学 心脏病学
- 发展生物学 发展生物学
- 遗传学 遗传学 是一个
背景情况:
- 先天性心脏缺陷 (CHD) 是一种常见的出生缺陷,其原因复杂.
- 遗传因素只能解释CHD的一部分,强调环境影响.
- 母亲孕期糖尿病增加了先天性心脏病的风险.
研究的目的:
- 审查受孕妇高血糖症影响的心脏发育的分子机制.
- 总结研究孕期糖尿病对胎儿心脏的影响的实验模型.
- 为了解和预防与糖尿病相关的慢性心血管疾病提出新的战略.
主要方法:
- 在高血糖条件下的心脏发育中的分子机制的文献综述.
- 在体内和体外孕期糖尿病实验模型的分析.
- 综合当前的知识和识别研究差距.
主要成果:
- 过高血糖被假定是糖尿病怀孕中的关键原体.
- 潜在的机制包括直接的遗传/表观遗传失调和反应性氧物种 (ROS) 生产.
- 现有的模型提供了洞察力,但需要进一步改进.
结论:
- 了解孕产妇高血糖受影响的分子通路对于心血管疾病研究至关重要.
- 需要改进的实验模型来阐明精确的机制.
- 在糖尿病母亲的后代中开发新的心血管疾病预防策略是关键目标.
相关概念视频
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
554
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
554
Inborn Errors of Metabolism
165
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
165


